Advertisement

Product › Details
CG01 gene therapy (CombiGene)
![]() |
Next higher product group | gene therapy epilepsy |
![]() |
Status | 2018-01-12 development existent |
Record changed: 2024-06-07 |
Advertisement

More documents for gene therapy epilepsy
- [1] CombiGene AB. (10/14/23). "Press Release: Spark Therapeutics Terminates Collaboration Agreement for the Epilepsy Project CG01 with CombiGene". Stockholm....
- [2] Kriya Therapeutics, Inc.. (11/16/22). "Press Release: Kriya Acquires Redpin Therapeutics, Adding Neurology Pipeline to Gene Therapy Portfolio". Redwood City, CA & Research Triangle Park, NC....
- [3] CombiGene AB. (12/16/21). "Press Release: CombiGene and Spark Therapeutics Plan to Expand the Clinical Development Program to Include the U.S. as Well as Europe"....
- [4] Spark Therapeutics, Inc.. (10/12/21). "Press Release: Spark Therapeutics and CombiGene Enter into Exclusive, Global Licensing Agreement for Gene Therapy Candidate CG01". Philadeliphia, PA....
- [5] Uniqure N.V.. (6/22/21). "Press Release: Uniqure to Acquire Corlieve Therapeutics and Advance its Gene Therapy Program to Treat Temporal Lobe Epilepsy (TLE)". Lexington, MA, Amsterdam & Paris....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top